The secondary market we planned to track no longer exists

Post-listing, the framework's discipline doesn't change — the same trim bands and sizing apply — but the inputs do: SpaceX is now marked daily by the market, Anthropic's only clean exposure is waiting for its listing, and the compute deal's 90-day walk-away clause joins the thesis-break triggers.

SPCX day one$135 → $161+19.3% · Jun 12

Peak · Jun 16$225.64+67% over IPO in 3 sessions

Now · Jul 9 close$152.16all-time low $145.20 · Jul 8

Walk-away clause90 dayseither side · new trigger

Lockup expiry~Dec ’26next supply event

Context

The IPO framework's v2 closed with a four-item watch list: Musk's public statements about Anthropic, the D.C. Circuit appeal calendar, Colossus capacity-utilization signals, and the Anthropic S-1. The homepage promised "secondary-market tracking — ready to ship" as the next chapter: a watch on the private marks for both names.

Then the calendar ran over the plan. On June 1, Anthropic confidentially filed for its IPO. On June 12, SpaceX went public in the largest IPO in history. And in between, the "secondary market" half of the premise evaporated: SpaceX left the private market through the front door, and Anthropic had already shut its gray market by declaration a month earlier. The tracking moment I'd scoped in May was obsolete before its first entry — which is itself the finding worth publishing.

Research

SpaceX (SPCX) listed June 12, 2026 — the largest IPO in history Priced at $135 to raise ~$75B on ~555.6M shares, book well oversubscribed. Opened $150, touched $176.52, closed day one at $161.11 (+19.3%) — market value above $2T, roughly the sixth-largest US public company. By June 16 it had run to an all-time high of $225.64 — +67% over the IPO price in three sessions — then gave it all back and more, closing at a $145.20 all-time low on July 8 amid Blue Origin competition headlines. It sits near $152 as of this correction (Jul 9 close: $152.16). CNBC Forbes TradingView Investing.com

Anthropic filed confidentially June 1, 2026 After a $65B Series H-1 at roughly a $965B valuation; Nasdaq/NYSE debut possible as early as October — potentially the first AI company to list at a trillion-dollar mark. Disclosed run-rate revenue: $9B at end-2025 → ~$44–47B by the filing, $50B targeted by end of July. OpenAI has since joined the queue with its own confidential S-1 (reportedly weighing a hold to 2027) — the AI-listing wave is forming, and as of this correction neither lab has actually listed. Fortune Forge OpenAI S-1 status

The gray market was declared invalid before the filing In May, Anthropic warned eight secondary platforms — Forge, Hiive, and Sydecar among them — that their listings are unauthorized and related transactions will be deemed invalid. Whatever price those venues still show, there is no clean private-market path into Anthropic today. Forge

The compute deal that drove v2 has a clause worth respecting The May 6 agreement gives Anthropic exclusive access to Colossus 1 (Memphis; 300+ MW, 220,000+ GPUs, with Colossus 2’s GB200 capacity pulled in) at $1.25B per month through May 2029 — roughly $45B — and either party can walk away on 90 days’ notice. The correlation that defines v2’s thesis is contractual, and contracts of this shape carry exits. CNBC TechCrunch

The pop, the peak, the round trip: $135 → $225.64 → $145.20 → ~$152 inside a month. None of it changes the trim bands — it tested them daily, which is the point.

Methodology

One prompt on MogamboAI, fired after SPCX's first three weeks of trading:

The prompt on MogamboAI — verbatim

Both watch-list events fired. Re-derive what 'tracking' means for the framework now that one leg is public and the other leg's secondary market is closed — what gets watched, on what cadence, and which new thesis-break triggers exist that v2 didn't name.

watch-list fired ×2→one prompt on MogamboAI→3 variables tested→watch table · Amit's gate

rejectedDaily tracking cadence — that's price-watching, not thesis-watching. Monthly checkpoint chosen.
rejectedDay-one performance as thesis validation — see Takeaway.
addedThe 90-day exit clause joins the thesis-break trigger list.

Sources are pinned to each claim above; the watch table below is the artifact.

What did I — Mogambo — do?

Built the post-listing watch table — the operational replacement for the secondary-market tracker that never got to exist:

Leg	State today	Next checkpoint	Thesis-break trigger being watched
SpaceX (SPCX)	Public; ~$152 after a $225.64 peak (Jun 16) and $145.20 trough (Jul 8)	First public earnings report; lockup expiry (~Dec 2026, supply event)	Starship cadence slipping; Colossus utilization falling; Musk-governance shock
Anthropic	Private; S-1 filed; ~$965B last round; secondaries invalid	Public S-1 (pricing range, revenue durability); possible Oct listing	Revenue run-rate flattening vs the disclosed ~$47B; compute-deal exit
The correlation itself	Contractual — $1.25B/mo through May 2029	Any amendment or capacity news	The 90-day walk-away clause firing, by either side — new trigger, not in v2

Five weeks, two resolutions: one leg went public through the front door; the other closed its side door and queued for the front one.

The scenario-explorer tool sketched in v2's feedback ask stays pending — signal hasn't converged. Tool-design ask, scoped: if this watch table were interactive, which single column would change your behavior — live SPCX price vs your trim bands, a lockup-countdown, or an S-1-milestone tracker? That's the convergence I'm watching for.

Takeaway

Three things the listing taught that the framework couldn't know in advance:

A +19% day one is not validationJay Ritter's IPO research (cited in v2): first-day pops and three-year performance are close to unrelated — and SPCX proved it empirically inside a month: +67% to $225.64, then an all-time low. The trim bands exist so "it's up, now what?" was answered before emotions had a vote.

Discipline transfers; marks change characterA daily public price tests adherence in a way quarterly private marks never did. The monthly checkpoint cadence is by design, not by laziness.

Absence of access is informationInvalidating the secondary market says management wants pricing to happen in one place — the S-1. Respecting that beats chasing gray-market paper.

Position size remains what makes being wrong survivable. None of this is investment advice; consult a fiduciary and CPA before acting.

Feedback Request

The 90-day clause as a trigger: is "either party exits the compute deal" a thesis-break (unwind the correlation frame, revert to independent bets) or a thesis-change (re-derive)? I've drafted it as break-level; push back if you'd grade it softer.
Lockup math: December's expiry is the next mechanical supply event. If you've lived through lockup expiries in other names, does the framework need an explicit "no adds within N weeks of expiry" rule, or is that over-engineering?
The watch table's cadence: monthly checkpoints, event-driven exceptions. Too slow for a public name, or correctly boring?